Evidence map›Paper›PMID 38545219›Full record

ArticleHeliyon2024

Heteroleptic (S^C)-cyclometallated gold(III) complexes as novel antiviral agents.

María Balsera-Manzanero, Raquel G Soengas, Marta Carretero-Ledesma, Carlos Ratia, M José Iglesias, Jerónimo Pachón, Fernando López-Ortiz, Elisa Cordero, Sara M Soto, Javier Sánchez-Céspedes

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

María Balsera-ManzaneroUnidad Clínica de Enfermedades Infecciosas, Microbiología y Parasitología, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.
Raquel G SoengasÁrea de Química Orgánica, Centro de Investigación CIAIMBITAL, Universidad de Almería, Spain.
Marta Carretero-LedesmaUnidad Clínica de Enfermedades Infecciosas, Microbiología y Parasitología, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.
Carlos RatiaBarcelona Institute for Global Health (ISGlobal), Universitat de Barcelona, Barcelona, Spain.
M José IglesiasÁrea de Química Orgánica, Centro de Investigación CIAIMBITAL, Universidad de Almería, Spain.
Jerónimo PachónInstituto de Biomedicina de Sevilla (IBiS), Hospitales Universitarios Virgen del Rocío y Virgen Macarena/CSIC/Universidad de Sevilla, Sevilla, Spain.
Fernando López-OrtizÁrea de Química Orgánica, Centro de Investigación CIAIMBITAL, Universidad de Almería, Spain.
Elisa CorderoUnidad Clínica de Enfermedades Infecciosas, Microbiología y Parasitología, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.
Sara M SotoBarcelona Institute for Global Health (ISGlobal), Universitat de Barcelona, Barcelona, Spain.
Javier Sánchez-CéspedesUnidad Clínica de Enfermedades Infecciosas, Microbiología y Parasitología, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.
Instituto de Biomedicina de Sevilla · ESInstituto de Salud Carlos III · ESUniversity of Almería · ESBarcelona Institute for Global Health · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the increasingly widespread clinical impact of adenovirus (HAdV) infections in healthy individuals and the associated high morbidity in immunosuppressed patients, particularly among the paediatric population, a specific treatment for this virus has yet to be developed. In this study, we report the anti-HAdV activity of sub-micromolar concentrations of four heteroleptic (C^S)-cycloaurated complexes bearing a single thiophosphinamide [

Indexed as

AdenovirusAntiviralsCycloaurated complexesMetallodrugs

Identifiers

PMID38545219
PMCPMC10965532
OpenAlexW4392961108

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.